| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 5,074,000 | 4,742,000 | | Cost of Revenue | 1,586,000 | 1,416,000 | | | Gross Profit | 3,488,000 | 3,326,000 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 1,481,000 | 1,370,000 | | Non Recurring | (42,000) | (11,000) | | Others | 569,000 | 525,000 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 1,480,000 | 1,442,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 66,000 | 53,000 | | Earnings Before Interest And Taxes | 2,261,000 | 2,020,000 | | Interest Expense | 636,000 | 633,000 | | Income Before Tax | 1,625,000 | 1,387,000 | | Income Tax Expense | 496,000 | 443,000 | | Minority Interest | (63,000) | (71,000) | | | | Net Income From Continuing Ops | 1,129,000 | 944,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 13,000 | | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 1,129,000 | 957,000 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $1,129,000 | $957,000 |
|
1.48% Nasdaq 
Income Statement
